Total Payments
$3,743
2024 Payments
$98.93
Companies
17
Transactions
106
Medicare Patients
1,544
Medicare Billing
$225,851
Payment Breakdown by Category
Food & Beverage$3,743 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,743 | 106 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,708 | 36 | $0 (2024) |
| Novo Nordisk Inc | $354.77 | 9 | $0 (2019) |
| Daiichi Sankyo Inc. | $334.69 | 14 | $0 (2019) |
| GlaxoSmithKline, LLC. | $313.06 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $308.46 | 7 | $0 (2018) |
| Phadia US Inc. | $238.61 | 6 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $100.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $96.76 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.86 | 4 | $0 (2019) |
| Allergan Inc. | $57.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.93 | 4 | Abbott Laboratories ($78.61) |
| 2023 | $145.96 | 4 | Abbott Laboratories ($145.96) |
| 2022 | $221.01 | 6 | Abbott Laboratories ($221.01) |
| 2021 | $292.21 | 3 | Abbott Laboratories ($292.21) |
| 2019 | $399.29 | 18 | Abbott Laboratories ($191.02) |
| 2018 | $1,531 | 56 | Abbott Laboratories ($545.31) |
| 2017 | $1,055 | 15 | Abbott Laboratories ($234.04) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Neuromodulation | ||||||
| 09/30/2024 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Neuromodulation | ||||||
| 06/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Neuromodulation | ||||||
| 06/20/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), RELTONE 400 MG, GLYCATE | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: GALLSTONES | ||||||
| 10/27/2023 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Neuromodulation | ||||||
| 08/21/2023 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $75.04 | General |
| Category: Neuromodulation | ||||||
| 06/09/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Neuromodulation | ||||||
| 04/21/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Neuromodulation | ||||||
| 11/11/2022 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Neuromodulation | ||||||
| 11/11/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neuromodulation | ||||||
| 10/04/2022 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $71.12 | General |
| Category: Neuromodulation | ||||||
| 07/01/2022 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: Neuromodulation | ||||||
| 05/19/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Neuromodulation | ||||||
| 02/14/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Neuromodulation | ||||||
| 10/20/2021 | Abbott Laboratories | Penta SCS Leads (Device) | Food and Beverage | In-kind items and services | $151.30 | General |
| Category: Neuromodulation | ||||||
| 09/28/2021 | Abbott Laboratories | Penta SCS Leads (Device) | Food and Beverage | In-kind items and services | $120.89 | General |
| Category: Neuromodulation | ||||||
| 05/11/2021 | Abbott Laboratories | Proclaim XR IPG (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Neuromodulation | ||||||
| 11/22/2019 | Abbott Laboratories | Lamitrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $38.88 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/05/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Neuroscience | ||||||
| 07/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/19/2019 | Abbott Laboratories | Penta SCS Leads (Device) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/01/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 231 | 434 | $210,479 | $40,899 |
| 2022 | 4 | 181 | 508 | $163,260 | $43,755 |
| 2021 | 14 | 724 | 1,014 | $269,119 | $96,669 |
| 2020 | 14 | 408 | 583 | $154,414 | $44,528 |
Total Patients
1,544
Total Services
2,539
Medicare Billing
$225,851
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 101 | 295 | $124,618 | $27,374 | 22.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 70 | 71 | $40,826 | $6,225 | 15.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 44 | $35,195 | $5,833 | 16.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 24 | $9,840 | $1,466 | 14.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 80 | 389 | $117,708 | $31,734 | 27.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 39 | $24,147 | $5,982 | 24.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 46 | 54 | $16,097 | $4,540 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 26 | $5,309 | $1,499 | 28.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 132 | 136 | $84,950 | $21,070 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 173 | $38,574 | $17,107 | 44.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 120 | $35,836 | $16,844 | 47.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 39 | 39 | $19,441 | $8,918 | 45.9% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2021 | 53 | 105 | $23,044 | $8,895 | 38.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 64 | 69 | $12,089 | $4,527 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 59 | $9,045 | $3,959 | 43.8% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2021 | 55 | 75 | $8,957 | $3,504 | 39.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 37 | $11,840 | $3,151 | 26.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 51 | 80 | $8,478 | $2,138 | 25.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 11 | 11 | $6,325 | $1,627 | 25.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 34 | $3,162 | $1,583 | 50.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 31 | 31 | $3,377 | $1,356 | 40.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 19 | 30 | $2,503 | $1,021 | 40.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 15 | 15 | $1,500 | $969.90 | 64.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 56 | 60 | $35,518 | $10,081 | 28.4% |
| G0181 | Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c | Office | 2020 | 33 | 73 | $16,022 | $6,516 | 40.7% |
About Dr. Irene Lambiris, M.D
Dr. Irene Lambiris, M.D is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1821309014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Irene Lambiris, M.D has received a total of $3,743 in payments from pharmaceutical and medical device companies, with $98.93 received in 2024. These payments were reported across 106 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,743).
As a Medicare-enrolled provider, Lambiris has provided services to 1,544 Medicare beneficiaries, totaling 2,539 services with total Medicare billing of $225,851. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Henderson, NV
- Active Since 06/23/2010
- Last Updated 03/31/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821309014
Products in Payments
- Penta SCS Leads (Device) $485.41
- PENTA (Device) $289.27
- ImmunoCAP (Device) $238.61
- TRELEGY ELLIPTA (Drug) $160.23
- Tresiba (Drug) $157.76
- Proclaim Family of SCS IPGs (Device) $157.00
- BEVESPI AEROSPHERE (Drug) $147.47
- Axium INS DRG IPG (Device) $129.42
- FARXIGA (Drug) $125.05
- Morphabond ER (Drug) $123.52
- Movantik (Drug) $121.84
- Octrode SCS Leads (Device) $120.08
- SHINGRIX (Biological) $117.26
- Victoza (Drug) $116.68
- DRG IPGs (Device) $108.43
- PRALUENT (Drug) $100.00
- DRG leads (Device) $93.32
- INJECTAFER (Drug) $89.33
- OCTRODE (Device) $84.27
- Ozempic (Drug) $80.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Internal Medicine $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Internal Medicine $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Internal Medicine $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Internal Medicine $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Internal Medicine $21,843
Dr. Justin Terry, Md, MD
Internal Medicine — Payments: $21,280
Internal Medicine $21,280